Participants 254 289 3
patients with respiratory allergies
Participants 536 640 5
Adult and pediatric patients with allergic rhinoconjunctivitis and/or asthma were included in the study.
Participants 641 672 3
Ten subjects served as controls
Participants 710 773 4
Forty-three subjects were allocated to sublingual immunotherapy
Participants 1354 1389 3
patients with respiratory allergies
